Literature DB >> 32544948

Pool Size Selection When Testing for Severe Acute Respiratory Syndrome Coronavirus 2.

Christopher R Bilder1, Peter C Iwen2,3, Baha Abdalhamid2,3.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 32544948      PMCID: PMC7337646          DOI: 10.1093/cid/ciaa774

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
To the Editor—Pooling samples has been proposed by multiple authors as an efficient way to test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1-4]. In particular, Yelin et al [1] showed that SARS-CoV-2 can be detected in pools with up to 32 samples and potentially in pools of 64 samples. They concluded that “this pooling method can be applied immediately in current clinical testing laboratories.” However, this research [1] and similar research of others [2, 3] missed answering a very important question: How does one choose the most efficient pool size relative to SARS-CoV-2 prevalence in samples? Without answering this question, laboratories cannot fully benefit from pooling. Here, we provide the answer so that laboratories can increase their testing capacity to its fullest potential. The efficiencies from pooling samples occur when pools test negative. In general, the probability of a negative pool ( is given by for a prevalence () and pool size () [5]. For example, the most efficient pool size is 4 samples when prevalence is 10% (calculation discussed below). This will lead to 66% of the pools testing negative on average, resulting in 3 tests saved for each negative pool. On the other hand, choosing a pool size that is too large can be very inefficient. By changing the size to 32 samples in our example, only 3% of the pools will test negative. We subsequently show that there are no benefits from using this pool size with this prevalence. Similar inefficiencies occur as well when selecting pool sizes that are too small. Yelin et al [1] identified a range of pool sizes that appear to not compromise testing sensitivity. From this range, one needs to determine the optimal pool size to perform testing most efficiently. Statistical research has shown, in general, that this is the pool size that minimizes the average number of tests on a per capita basis ( when testing a continuous series of samples, where is a mathematical function of prevalence [5-7]. Separate testing of each sample corresponds to , and pooling is more efficient when Expressions for are available [5-7], and the optimal pool size can be approximated by the next integer larger than [8] or found exactly [9, 10]. Table 1 provides for prevalences between 0.001 and 0.20. For example, a prevalence of 2% results in an optimal pool size of 8 and  = 0.27. This corresponds to a 73% average reduction in tests from pooling. Equivalently, this can mean a 264% increase in testing capacity when compared with testing samples separately. Table 1 also includes for the same pool sizes as investigated by Yelin et al [1]. These additional results illustrate the importance of choosing pool size relative to prevalence. For example, while SARS-CoV-2 can be detected in pools of size 32, this size is optimal only for the smallest prevalence. In fact, for prevalences larger than 0.10, indicating that pooling results in more tests on average than separate testing.
Table 1.

Average Number of Tests Per Capita (A ) Relative to Prevalence

Prevalence (%)Optimal A for Specified Pool Size
Pool Size A 248163264
0.1320.060.500.250.130.080.060.08
0.5150.140.510.270.160.140.180.29
1110.200.520.290.200.210.310.49
280.270.540.330.270.340.510.74
360.330.560.360.340.450.650.87
460.380.580.400.400.540.760.94
550.430.600.440.460.620.840.98
650.470.620.470.520.690.891.00
740.500.640.500.570.750.931.01
840.530.650.530.610.800.961.01
940.560.670.560.650.840.981.01
1040.590.690.590.690.881.001.01
1140.620.710.620.730.911.011.02
1240.650.730.650.770.931.011.02
1330.670.740.680.800.951.021.02
1430.700.760.700.830.971.021.02
1530.720.780.730.850.991.031.02
1630.740.790.750.881.001.031.02
1730.760.810.780.901.011.031.02
1830.780.830.800.921.021.031.02
1930.800.840.820.941.031.031.02
2030.820.860.840.961.031.031.02

Calculations are performed using the binGroup2 package [10] of the R statistical software environment. Abbreviation: A, average number of tests per capita.

Average Number of Tests Per Capita (A ) Relative to Prevalence Calculations are performed using the binGroup2 package [10] of the R statistical software environment. Abbreviation: A, average number of tests per capita.
  11 in total

1.  Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission: An Italian Sample.

Authors:  Veronica Cian; Alessandro De Laurenzis; Chiara Siri; Anna Gusmeroli; Margherita Canesi
Journal:  Front Psychol       Date:  2022-05-24

2.  Sample pooling as a strategy for community monitoring for SARS-CoV-2.

Authors:  Rafal Sawicki; Izabela Korona-Glowniak; Anastazja Boguszewska; Agnieszka Stec; Malgorzata Polz-Dacewicz
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

3.  Pooled nasopharyngeal swab collection in a single vial for the diagnosis of SARS CoV-2 infection: An effective cost saving method.

Authors:  Reshu Agarwal; Ekta Gupta; Shantanu Dubey; Abhishek Padhi; Arvind Khodare; Guresh Kumar; Shiv Kumar Sarin
Journal:  Indian J Med Microbiol       Date:  2021-01-27       Impact factor: 0.985

4.  A robust pooled testing approach to expand COVID-19 screening capacity.

Authors:  Douglas R Bish; Ebru K Bish; Hussein El-Hajj; Hrayer Aprahamian
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

5.  Spatial technologies to strengthen traditional testing for SARS-CoV-2.

Authors:  Shujuan Yang; Xiongfeng Pan; Peibin Zeng; Peng Jia
Journal:  Trends Microbiol       Date:  2021-03-14       Impact factor: 17.079

6.  Safe and effective pool testing for SARS-CoV-2 detection.

Authors:  Marie Wunsch; Dominik Aschemeier; Eva Heger; Denise Ehrentraut; Jan Krüger; Martin Hufbauer; Adnan S Syed; Gibran Horemheb-Rubio; Felix Dewald; Irina Fish; Maike Schlotz; Henning Gruell; Max Augustin; Clara Lehmann; Rolf Kaiser; Elena Knops; Steffi Silling; Florian Klein
Journal:  J Clin Virol       Date:  2021-10-28       Impact factor: 3.168

7.  Diagnostic performance of RT-PCR-based sample pooling strategy for the detection of SARS-CoV-2.

Authors:  Miguel Hueda-Zavaleta; Cesar Copaja-Corzo; Vicente A Benites-Zapata; Pedro Cardenas-Rueda; Jorge L Maguiña; Alfonso J Rodríguez-Morales
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-03-14       Impact factor: 3.944

8.  Group testing via hypergraph factorization applied to COVID-19.

Authors:  David Hong; Rounak Dey; Xihong Lin; Brian Cleary; Edgar Dobriban
Journal:  Nat Commun       Date:  2022-04-05       Impact factor: 14.919

9.  Pathology Informatics and Robotics Strategies for Improving Efficiency of COVID-19 Pooled Testing.

Authors:  Balaji Balasubramani; Kimberly J Newsom; Katherine A Martinez; Petr Starostik; Michael Clare-Salzler; Srikar Chamala
Journal:  Acad Pathol       Date:  2021-06-15

Review 10.  Sample pooling: burden or solution?

Authors:  Nadja Grobe; Alhaji Cherif; Xiaoling Wang; Zijun Dong; Peter Kotanko
Journal:  Clin Microbiol Infect       Date:  2021-04-18       Impact factor: 13.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.